As part of the network, Medable will work with the center to develop the Human Heart Digitome, expected to be the largest real-world database specifically for the understanding and treatment of cardiovascular disease. Patient data in the registry will not only be used in research and clinical trials, but will also be analyzed with Medable’s predictive analytics tools to help physicians identify at-risk patients and improve outcomes.
Members of the Innovators Network are selected to combine their technology with the AHA’s own digital resources in order to develop high-tech solutions to advance knowledge and treatment of cardiovascular disease. Other members include Livongo, Biofourmis and PAI Health, a software company offering heart rate-tracking data analytics technology that joined the network in June.
More articles on innovation:
MD Anderson, Boehringer launch virtual center for data-driven drug discovery
6 key quotes about innovation’s role in healthcare
Apple Health researcher jumps ship for Gates Foundation’s digital health group
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
